Detalles de la búsqueda
1.
Evaluation of PXL065 - deuterium-stabilized (R)-pioglitazone in patients with NASH: A phase II randomized placebo-controlled trial (DESTINY-1).
J Hepatol
; 78(5): 914-925, 2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-36804402
2.
Efficacy and safety of imeglimin add-on to insulin monotherapy in Japanese patients with type 2 diabetes (TIMES 3): A randomized, double-blind, placebo-controlled phase 3 trial with a 36-week open-label extension period.
Diabetes Obes Metab
; 24(5): 838-848, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-34984815
3.
Phase 2 trial with imeglimin in patients with Type 2 diabetes indicates effects on insulin secretion and sensitivity.
Endocrinol Diabetes Metab
; 5(6): e371, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36239048
4.
Efficacy and Safety of Imeglimin Monotherapy Versus Placebo in Japanese Patients With Type 2 Diabetes (TIMES 1): A Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Multicenter Phase 3 Trial.
Diabetes Care
; 44(4): 952-959, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33574125
5.
Bioavailability of a co-formulated combination of amodiaquine and artesunate under fed and fasted conditions. A randomised, open-label crossover study.
Arzneimittelforschung
; 59(7): 370-6, 2009.
Artículo
en Inglés
| MEDLINE | ID: mdl-19728565
Resultados
1 -
5
de 5
1
Próxima >
>>